Kuo S C, Ibuka T, Huang L J, Lien J C, Yean S R, Huang S C, Lednicer D, Morris-Natschke S, Lee K H
Graduate Institute of Pharmaceutical Chemistry, China Medical College, Taichung, Taiwan, Republic of China.
J Med Chem. 1996 Mar 29;39(7):1447-51. doi: 10.1021/jm950247k.
As part of our continuing search for potential anticancer drug candidates that are selective against slowly growing solid tumors, we have synthesized several series of 1- and 2-substituted derivatives of the lead structure, 1-ethyl-2-methylnaphth[2,3-d]imidazole-4,9-dione (5). Their cytotoxic activity in the National Cancer Institute's in vitro cancer cell line panel is reported. In general, substitution of various alkyl, phenyl, or benzyl moieties did not improve activity, and compound 5 remains the most active naphth[2,3-d]imidazole-4,9-dione derivative. However, high levels of activity and selectivity were found with several related 2-(acylamino)-3-chloro-1,4-naphthoquinones (2f-j). Compound 2i, 2-[(2-fluorophenyl)acetamido]-3-chloro-1,4-naphthoquinone, has been selected for further in vivo testing and as an additional lead compound for further structural modification.
作为我们持续寻找对生长缓慢的实体瘤具有选择性的潜在抗癌药物候选物工作的一部分,我们合成了先导结构1-乙基-2-甲基萘并[2,3-d]咪唑-4,9-二酮(5)的几个系列的1-和2-取代衍生物。本文报道了它们在美国国立癌症研究所体外癌细胞系面板中的细胞毒性活性。一般而言,各种烷基、苯基或苄基部分的取代并未提高活性,化合物5仍然是活性最高的萘并[2,3-d]咪唑-4,9-二酮衍生物。然而,几种相关的2-(酰氨基)-3-氯-1,4-萘醌(2f-j)表现出高活性和选择性。化合物2i,2-[(2-氟苯基)乙酰氨基]-3-氯-1,4-萘醌,已被选用于进一步的体内测试,并作为进一步结构修饰的另一种先导化合物。